Accuray (ARAY) reported $459M in revenue for fiscal 2025, +2.7% year on year. That ranks #2266 by revenue among 2853 SEC filers and #222 in Healthcare. It posted a net loss of −$1.6M for the same year. Revenue has grown 1.6% a year on average since 2016 ($399M then). The fiscal 2025 balance sheet shows $448M in total assets, $41.3M in cash and $125M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $459M | +2.7% | FY20252025-06-30 |
| Gross profitGrossProfit | $147M | +2.8% | FY20252025-06-30 |
| Operating incomeOperatingIncomeLoss | $7.8M | +1,455.4% | FY20252025-06-30 |
| Net incomeNetIncomeLoss | −$1.6M | +$14.0M | FY20252025-06-30 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $2.9M | +$14.8M | FY20252025-06-30 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $4.3M | +18.6% | FY20252025-06-30 |
| Total assetsAssets | $448M | −6.3% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $53.4M | +11.5% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $41.3M | −34.0% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $125M | −25.7% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $105M | −$11.8M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Profile
- Legal name
- Accuray Inc
- Ticker
- ARAY
- Exchange
- Nasdaq
- SIC classification
- Surgical & Medical Instruments & Apparatus (3841)
- Fiscal year end
- 06-30
- CIK
- 0001138723
Filings
- 10-KAug 27, 2026Open filing →
- 10-QMay 6, 2026Open filing →
- 10-QFeb 17, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Porch GroupPRCH | $482M | −$3.4M |
| Natures Sunshine ProductsNATR | $480M | $19.5M |
| Zai LabZLAB | $460M | −$176M |
| AccurayARAY | $459M | −$1.6M |
| Tarsus PharmaceuticalsTARS | $451M | −$66.0M |
| ArtivionAORT | $441M | $9.8M |
| Genedx HoldingsWGS | $428M | −$21.0M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Accuray — Key figures |url=https://companiesranked.com/en/company/accuray |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Accuray — Key figures. CompaniesRanked. https://companiesranked.com/en/company/accurayBibTeX
@misc{companiesranked-en-company-accuray-2026,
author = {{CompaniesRanked}},
title = {{Accuray — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/accuray}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001437749-26-029098 · August 27, 2026
{{cite web |title=Accuray — Key figures — 10-K (0001437749-26-029098) |url=https://www.sec.gov/Archives/edgar/data/1138723/000143774926029098/aray20260630_10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.